Provention bio reports fourth quarter and full year 2021 financial results and provides business update

Red bank, n.j., feb. 24, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial results for the fourth quarter and full year ended december 31, 2021, and provided a business update.
PRVB Ratings Summary
PRVB Quant Ranking